Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia.
Mohammad EjazMuhammad Ali SyedCharlene R JacksonMehmoona SharifRani FaryalPublished in: Antibiotics (Basel, Switzerland) (2023)
Staphylococcus aureus is one of the ESKAPE ( Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter species) pathogens among which multidrug resistance has emerged. Resistance to methicillin has resulted in clinicians using the antibiotic of last resort, vancomycin, to treat infections caused by methicillin-resistant S. aureus (MRSA). However, excessive use and misuse of vancomycin are major causes of resistance among S. aureus strains. South Asia encompasses ~25% of the world's population, and countries in South Asia are often characterized as low- and middle-income with poor healthcare infrastructure that may contribute to the emergence of antibiotic resistance. Here, we briefly highlight the mechanism of vancomycin resistance, its emergence in S. aureus , and the molecular epidemiology of non-susceptible S. aureus to vancomycin in the South Asian region.
Keyphrases